New ClusterStor L300N System Addresses the #2 Roadblock in HPC

Hyperion identified storage access time as the #2 roadblock in HPC. The newly announced ClusterStor™ L300N hybrid storage system with intelligent NXD software is purpose-engineered to address the mixed I/O bottleneck that many HPC users are facing as they run more and more applications on the same system. In fact, this software innovation delivers up to 1,000 percent I/O workload acceleration over traditional HPC storage systems. The NXD I/O manager monitors incoming I/O in real time and optimizes data access by directing large-block writes directly to HDDs while small writes are sent to SSDs. Once the small writes have been coalesced on the SSDs, the blocks are flushed to the HDDs. This allows completely transparent, efficient I/O ... [ Read More ]

How to Program a Supercomputer

We felt that it was necessary to write a book reintroducing programming techniques that should be used by application developers targeting the current and future generation supercomputers. While the techniques have been around for a long time, many of today’s developers are not aware of them. Let us explain. The supercomputer has been a shifting target for application programmers ever since its inception in the form of Seymour Cray’s CDC 6600 in the early 1970s, forcing developers to adapt to new approaches along with the ever-changing hardware and software systems. This necessity of developer adaptation is especially conspicuous in the field of high-performance computing (HPC), where developers typically optimize for the target node ... [ Read More ]

Cray and Microsoft Partner to Bring Cray Supercomputers to Azure

This week we announced an exciting new strategic alliance with Microsoft that will make Cray systems available in Microsoft Azure, giving users access to all the supercomputing power they need without the overhead of owning and maintaining a datacenter. Cray in Azure will open up the power of supercomputing to a broad new cross-section of businesses and organizations with growing mission-critical, scalable applications needs. The dramatic growth in AI, machine and deep learning, and data analytics is driving the need for scalable simulation capability — and vice-versa — in a virtuous cycle where companies and organizations will vie for competitive advantage. Our CEO, Pete Ungaro, stated it well: “Our partnership with Microsoft will ... [ Read More ]

AI: Science Fact vs. Science Fiction (Part 2: Beyond Robots)

In the first installment of this 3-part series about artificial intelligence in science fiction vs. real-life AI, we talked about robots. Robots may be the first thing that comes to mind when hearing the term “artificial intelligence,” but humanoid robots are only a small part of today’s AI. Machines are capable of digesting massive amounts of data, learning how to deal with each piece, and making “decisions” about how to process it. As machine learning and real-world artificial intelligence becomes an increasingly critical part of today’s scientific and business environments, it is, in some ways, catching up with how it has been depicted in sci-fi books and movies — but there’s still a gulf between fact and fiction. ... [ Read More ]

Leading the Charge for Cancer Research

Prof. Rick Stevens with Argonne National Laboratory is using deep learning to help move science closer to curing cancer.

Cancer has proven itself a formidable opponent. But every opponent has a weakness — and Rick Stevens is working to identify it, exploit it... and, ultimately, bring the disease to its knees. How? With supercomputing-powered deep learning. Prof. Stevens is an associate laboratory director at Argonne National Laboratory (ANL) and a principal investigator on a program that’s part of the “Cancer Moonshot” — a sweeping “all government” approach to the problem of cancer. Called the Joint Design of Advanced Computing Solutions for Cancer (JDACS4C), the program relies on team science, bringing the combined forces of U.S. Department of Energy (DOE) supercomputing labs and the National Cancer Institute (NCI) and its national ... [ Read More ]